These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11079013)

  • 21. Hepatitis C in liver allografts.
    Thung SN; Shim KS; Shieh YS; Schwartz M; Theise N; Borcich A; Katz E; Miller C; Gerber MA
    Arch Pathol Lab Med; 1993 Feb; 117(2):145-9. PubMed ID: 8381267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
    Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
    Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.
    Shindo M; Arai K; Sokawa Y; Okuno T
    Ann Intern Med; 1995 Apr; 122(8):586-91. PubMed ID: 7887552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.
    Demetris AJ; Eghtesad B; Marcos A; Ruppert K; Nalesnik MA; Randhawa P; Wu T; Krasinskas A; Fontes P; Cacciarelli T; Shakil AO; Murase N; Fung JJ; Starzl TE
    Am J Surg Pathol; 2004 May; 28(5):658-69. PubMed ID: 15105656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological pattern of hepatitis C virus recurrence after liver transplantation.
    Rehermann B; Seifert U; Tillmann HL; Michel G; Böker KH; Pichlmayr R; Manns MP
    J Hepatol; 1996 Jan; 24(1):15-20. PubMed ID: 8834019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study.
    Sallie R; Cohen AT; Tibbs CJ; Portmann BC; Rayner A; O'Grady JG; Tan KC; Williams R
    J Hepatol; 1994 Oct; 21(4):536-42. PubMed ID: 7814799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels.
    Doughty AL; Spencer JD; Cossart YE; McCaughan GW
    Liver Transpl Surg; 1998 Jan; 4(1):15-21. PubMed ID: 9457962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of liver hepatitis C virus RNA and hepatitis C virus genotype on FAS-mediated apoptosis after liver transplantation for hepatitis C.
    Di Martino V; Brenot C; Samuel D; Saurini F; Paradis V; Reynés M; Bismuth H; Féray C
    Transplantation; 2000 Nov; 70(9):1390-6. PubMed ID: 11087158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of liver biopsy in anti-hepatitis C virus antibody-positive and hepatitis C virus RNA-negative kidney transplant recipients.
    Kim SM; Kim HW; Lee EK; Park SK; Han DJ; Kim SB
    Transplantation; 2013 Jul; 96(1):85-90. PubMed ID: 23632392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic and replicative hepatitis C virus RNA sequences and histologic activity in chronic hepatitis C.
    Chu HW; Dash S; Gerber MA
    Hum Pathol; 1994 Feb; 25(2):160-3. PubMed ID: 8119715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group.
    Hollingsworth RC; Sillekens P; van Deursen P; Neal KR; Irving WL
    J Hepatol; 1996 Sep; 25(3):301-6. PubMed ID: 8895008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
    Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S
    Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virologic and histologic characterisation of dual hepatitis B and C co-infection in Egyptian patients.
    Mekky MA; Nasr AM; Saleh MA; Wasif NK; Khalaf M; Aboalam H; Haredy M
    Arab J Gastroenterol; 2013 Dec; 14(4):143-7. PubMed ID: 24433642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.